The effect of ageing on the hepatic clearance of propranolol

British Journal of Clinical Pharmacology
C M Castleden, C F George


1. Plasma propranolol concentrations were measured in healthy old and young subjects following single oral doses of 40 mg, single i.v. infusions of 0.15 mg kg-1 and after nine 40 mg oral doses given four times daily. 2. In each of the three studies, the elderly had higher plasma propranolol concentrations than the young despite having similar apparent volumes of distribution. 3. The terminal half-life of propranolol was similar in the two groups after oral propranolol but significantly shorter in the young after intravenous dosing (P less than 0.05). 4. The bioavailability assessed from the concentration-time curves after i.v. and oral dosing was greater in the elderly (P less than 0.05). 5. The differences between peak concentrations observed in old and young subjects after single oral doses were maintained during chronic therapy and there was a correlation between the individual values obtained on multiple therapy with that after a single dose (P less than 0.05). 6. Ageing appears to affect the pharmacokinetics of propranolol in two ways. Firstly, distribution to the tissues appears to be slowed. Secondly, the increased bioavailability following oral administration suggests diminished intrinsic clearance by metabolism.


Jul 1, 1976·The Journal of Pharmacy and Pharmacology·L Saunders, T Natunen
Aug 1, 1976·Clinical Pharmacology and Therapeutics·D G McDevittD G Shand
Apr 1, 1976·British Journal of Clinical Pharmacology·S Wallace, B Whiting
Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Oct 1, 1975·Clinical Pharmacology and Therapeutics·R E VestalR Andres
Feb 1, 1975·British Journal of Clinical Pharmacology·M J HayesA H Short
Feb 1, 1975·British Journal of Clinical Pharmacology·M J HayesA H Short
Feb 1, 1976·Journal of Pharmacokinetics and Biopharmaceutics·C F GeorgeC T Dollery
Sep 26, 1970·British Medical Journal·D J Coltart, D G Shand
Jan 1, 1972·Pharmacology·D G ShandG H Evans
Jan 1, 1972·Journal of Pharmaceutical Sciences·M Rowland
May 1, 1972·Clinical Pharmacology and Therapeutics·C F George, C T Dollery
Jan 1, 1970·Clinical Pharmacology and Therapeutics·D G ShandJ A Oates
Sep 11, 1971·British Medical Journal·K O'MalleyI H Stevenson
Jan 1, 1969·Journal of Pharmaceutical Sciences·P A Harris, S Riegelman
Oct 1, 1955·Circulation·M BRANDFONBRENERN W Shock
Oct 1, 1961·The Journal of Clinical Endocrinology and Metabolism·C D WESTE ENGLERT
Mar 1, 1965·Journal of the American Geriatrics Society·A D BENDER


Feb 1, 1992·Journal of Clinical Pharmacology·M Piquette-MillerF Jamali
Jul 1, 1994·Journal of Clinical Pharmacology·E G GiardinaR Sciacca
Jan 1, 1993·European Journal of Clinical Pharmacology·T ShigaA Ebihara
Jan 1, 1990·European Journal of Clinical Pharmacology·A WesslingF Sjöqvist
Jan 1, 1982·European Journal of Clinical Pharmacology·L HolmbergM Ehrnebo
Jan 1, 1988·European Journal of Clinical Pharmacology·R L Logan
Jan 1, 1982·European Journal of Clinical Pharmacology·C HamdyJ McAinsh
Jan 1, 1984·European Journal of Clinical Pharmacology·H M NorburyS J Warrington
Jan 1, 1985·European Journal of Clinical Pharmacology·B CusackJ G Kelly
Jan 1, 1981·European Journal of Clinical Pharmacology·J FeelyI H Stevenson
Jan 1, 1989·European Journal of Clinical Pharmacology·K N DaviesC Jagger
Feb 1, 1981·European Journal of Clinical Pharmacology·K TawaraS Yoshida
Jan 1, 1986·European Journal of Clinical Pharmacology·I GretzerF Sjöqvist
Jan 1, 1983·European Journal of Clinical Pharmacology·C G RegårdhP O Lagerström
Jan 1, 1984·European Journal of Clinical Pharmacology·R BendayanG J Caranasos
Nov 1, 1983·Mechanisms of Ageing and Development·M S Bitar, M Weiner
Apr 1, 1987·Mechanisms of Ageing and Development·M S Bitar, B H Shapiro
Jan 1, 1983·Pharmacology & Therapeutics·A J Scriven, P J Lewis
Jan 1, 1988·Pharmacology & Therapeutics·J Roberts, N Tumer
Aug 23, 1980·Lancet·L H Opie
Jun 28, 1980·Lancet·J M Cruickshank
Sep 5, 2002·International Journal of Cardiology·Jaffar Ali Raza, Assad Movahed
May 1, 1980·The New England Journal of Medicine·E S Vesell
Jun 19, 1980·The New England Journal of Medicine·J Koch-WeserE T O'Brien
May 6, 1982·The New England Journal of Medicine·D J GreenblattR I Shader
Jun 19, 2007·Cardiology in Review·Wilbert S AronowAngela Cheng-Lai
Mar 21, 2009·American Journal of Therapeutics·John T MondickJeffrey S Barrett
Oct 1, 1990·British Journal of Clinical Pharmacology·H A WynneK W Woodhouse
Nov 1, 1991·British Journal of Clinical Pharmacology·G J MacpheeH L Elliott
Jan 1, 1992·British Journal of Clinical Pharmacology·H H ZhouA J Wood
Jun 16, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·H Simon SchaafPeter D O Davies
Jan 1, 1991·Fundamental & Clinical Pharmacology·O Spreux-VaroquauxC Advenier
Dec 1, 1996·The Journal of Pharmacy and Pharmacology·N SugiokaK Nakajima
Jan 1, 1986·Postgraduate Medical Journal·M Chellingsworth, D G Beevers
Oct 7, 2004·Biological & Pharmaceutical Bulletin·Masato TaguchiYukiya Hashimoto
Apr 11, 2008·Clinical Pharmacokinetics·Jennifer M Butler, Evan J Begg
Jul 12, 2012·Journal of Geriatric Cardiology : JGC·Hon-Chi LeeWin-Kuang Shen
Feb 26, 2013·The Journal of Antimicrobial Chemotherapy·Alan WinstonUK Collaborative HIV Cohort Study
Oct 12, 2010·Digestive Diseases and Sciences·Susumu EguchiTakashi Kanematsu
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Klaus Turnheim
Feb 14, 2015·Expert Opinion on Drug Safety·László VécseiJános Tajti
Jan 21, 2015·Expert Opinion on Drug Metabolism & Toxicology·Emily ReeveA A Mangoni
Jan 1, 1983·Drug Metabolism Reviews·E M SellersM K Romach
Dec 18, 2003·British Journal of Clinical Pharmacology·A A Mangoni, S H D Jackson
Oct 1, 1983·British Journal of Clinical Pharmacology·A J BayerS I Ankier
Jun 1, 1983·Journal of Clinical and Hospital Pharmacy·S Hutchison, L M Campbell
Aug 1, 1980·British Journal of Clinical Pharmacology·R E SchneiderM J Kendall
Jun 1, 1987·Baillière's Clinical Haematology·H A Wynne, K W Woodhouse
Mar 1, 1981·British Journal of Clinical Pharmacology·C P QuartermanD B Jack
Sep 1, 1981·British Journal of Clinical Pharmacology·P C RubinJ L Reid
Jul 1, 1981·British Journal of Clinical Pharmacology·J FeelyI H Stevenson
May 21, 2005·The American Journal of Geriatric Pharmacotherapy·Barry J Cusack
Nov 21, 2014·British Journal of Clinical Pharmacology·Annette GilchristJames M Ritter
Dec 17, 2014·Future Cardiology·Fayaz A Hakim, Win-Kuang Shen
Jan 1, 1981·Biopharmaceutics & Drug Disposition·G P MouldV Marks
Oct 1, 1990·Chest·W B Abrams
Feb 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H A WynneO F James
Apr 1, 1986·Journal of the Royal Society of Health·J Cox, K O'Malley
Jan 1, 1989·Biopharmaceutics & Drug Disposition·S S ChuaE J Triggs
Jul 1, 1992·Biopharmaceutics & Drug Disposition·K W Woodhouse
Jan 1, 1987·Journal of Clinical Pharmacology·J Dunn
Sep 26, 2018·Expert Opinion on Drug Metabolism & Toxicology·Federico Pea
Jan 1, 1984·Annals of the New York Academy of Sciences·P A Routledge
Jan 1, 1986·Acta Psychiatrica Scandinavica. Supplementum·C G Swift
Jul 6, 2014·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Khaled AbduljalilAmin Rostami-Hodjegan
Jan 24, 2020·The Tohoku Journal of Experimental Medicine·Ichiro YoshiiNaoya Sawada
Aug 2, 2017·Advanced Pharmaceutical Bulletin·Ebrahim SalehifarPouneh Ebrahimi
Mar 1, 1982·Journal of the American Geriatrics Society·R E Vestal
Jan 1, 1982·Acta Medica Scandinavica. Supplementum·C G Regårdh
Mar 28, 1998·British Journal of Clinical Pharmacology·M F FrommU Klotz
Apr 1, 1984·Australian and New Zealand Journal of Medicine·P C Ho, E J Triggs
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·H Storm-MathisenK Landmark
Jul 1, 1985·The Journal of Pharmacy and Pharmacology·K IwamotoH Sugiyama
Jul 25, 2019·Pharmacology Research & Perspectives·Frederik N Ågesenfor ESCAPE‐NET
Jun 1, 1988·Journal of Clinical Pharmacology·B Cusack
Apr 24, 2003·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Yusuke Tanigawara
Oct 28, 2017·British Journal of Clinical Pharmacology·Alper DaskapanJan-Willem C Alffenaar
Aug 3, 1989·The New England Journal of Medicine·S C MontamatR E Vestal

Related Concepts

Biological Availability
Intravenous Injections

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Related Papers

British Journal of Clinical Pharmacology
C M CastledenR L Parsons
British Journal of Clinical Pharmacology
J G KellyE T O'Brien
British Journal of Clinical Pharmacology
R E SchneiderM J Kendall
British Journal of Clinical Pharmacology
C P QuartermanD B Jack
© 2021 Meta ULC. All rights reserved